Top 10 Hot Stocks with the Highest Upside Potential
In this article, we will be taking a look at the Top 10 Hot Stocks with the Highest Upside Potential.
Oruka Therapeutics Inc. (ORKA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Paradigm Biocapital Advisors Senai Asefaw | 2,144,526 | $204,094,539 | -8% | 3.82% |
| 2. | Deep Track Capital David Kroin | 1,926,000 | $183,297,420 | -6% | 2.67% |
| 3. | Remedium Capital Partners David Hawkins | 1,565,661 | $149,003,957 | 32.99% | |
| 4. | RA Capital Management Peter Kolchinsky | 1,554,597 | $147,950,996 | 1.29% | |
| 5. | Viking Global Andreas Halvorsen | 1,503,478 | $143,086,001 | -44% | 0.41% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.44 | 88,794 | $1,015,803.36 | 4,148,428 | 2025-02-14 | Filing | |
| $11.63 | 14,950 | $173,868.50 | 4,059,634 | 2025-02-13 | Filing | |
| $11.86 | 8,971 | $106,396.06 | 4,044,684 | 2025-02-12 | Filing | |
| $10.95 | 9,593 | $105,043.35 | 4,035,713 | 2025-02-11 | Filing | |
| $10.90 | 574 | $6,256.60 | 4,026,120 | 2025-02-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $95.71 | 947 | $90,637.37 | 31,771 | 2026-09-15 | Filing | |
| $94.22 | 100 | $9,421.72 | 32,718 | 2026-09-15 | Filing | |
| $92.99 | 1,366 | $127,022.70 | 32,818 | 2026-09-15 | Filing | |
| $92.03 | 3,150 | $289,889.78 | 34,184 | 2026-09-15 | Filing | |
| $91.10 | 2,384 | $217,173.34 | 37,334 | 2026-09-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,057,645 | $862,016,075 | 0.04% | |
| 2. | 4,990,181 | $474,915,526 | 0.01% | |
| 3. | 4,148,428 | $394,805,893 | 11.97% | |
| 4. | 3,705,262 | $352,629,785 | 23.31% | |
| 5. | 3,401,639 | $323,733,984 | 0.04% |
News See All
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
Oruka Therapeutics, Inc. (NASDAQ:ORKA) is one of the best performing healthcare stocks so far in 2026. Leerink Partners lifted the price target on Oruka Therapeutics, Inc.
10 Best Performing Healthcare Stocks So Far in 2026
In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2026.
10 Small-Cap Stocks That Are On Fire Right Now
In this article, we will discuss the 10 Small-Cap Stocks That Are On Fire Right Now.
10 Stocks Racking Up Monster Gains
Ten stocks stood firmer on Monday, bucking a mixed performance in the broader market, as investors took heart from a flurry of company-specific developments and an improving macroeconomic front.
H.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 Trial
On May 27, analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Oruka Therapeutics, Inc. (NASDAQ:ORKA) while keeping the price target at $45.
Hedge Fund Resource Center